Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
124 Cards in this Set
- Front
- Back
what are the ways in which drugs can be transported across membranes? (4) which of these require energy & which of these require a carrier?
|
passive diffusion
facilitated diffusion (carrier) aqueous channels active transport (energy & carrier) |
|
what drives passive diffusion of a drug across a membrane? (2)
|
concentration gradient across membrane
lipid:water partition coefficient of the drug (greater cooefficient, high conc drug in membrane & faster diffusion) |
|
what drives passive diffusion of ionic compound? why?
|
its pKa
pH gradient across the membrane very small compounds can be carried in bulk water flow (molecular weight less than 200) since they are not soluble in lipid |
|
how are drugs passed across most capilliary endothelial membranes? with which exception & why
|
bulk flow through intercellular pores
tight junctions in CNS capillaries limit this intercellular diffusion |
|
what defines facilitated diffusion?
|
carrier - mediated transport process that does not require energy (ie movement of substance is not against an electrochemical gradient)
|
|
when is facilitated diffusion useful?
|
when the rate of movement across the membrane by simple diffusion would otherwise be too slow
|
|
how does active transport differ from facilitated diffusion?
|
it is identical except that ATP powers the drug transport against a concentration gradient
|
|
what, generally speaking, is pharmacokinetics?
|
what the body does to the drug
|
|
what is the definition of drug absorption?
|
the rate at which a drug leaves site of administration & extent to which this occurs
|
|
what concept is more clinically useful than drug absorption?
|
bioavailability - proportion of administered dose reaching the systemic circulation
|
|
what does drug absorption ultimately depend on, regardless of site?
|
drug solubility
|
|
what are drug factors influencing absorption? (5)
|
ionization state
molecular weight solubility (lipophilicity) formulation (solution versus tablet) concentration (increased conc absorbed more rapidly) |
|
what patient factors influence drug absorption?
|
- local conditions at site of absorption
- pH local anaesthetic - presence of food in gastro tract - circulation to site of absorption - surface area of absorbing surface (determined by route of admin) |
|
what features of a drug favour absorption in the GI tract? why?
|
non ionized & lipophilic
since most GI absorption occurs via passive process |
|
why is the stomach a poor absorber of drugs?
|
thick mucous membrane
low surface area increased electrical resistance |
|
why does gastric emptying increase drug absorption?
|
intestine has a thin, low resistance membrane & a high surface area
so pushing drug from low absorbing stomach to high absorbing intestine increases drug absorption rate |
|
how does enteric coating influence drug absorption in the GI tract? (2)
|
prevents drugs being destroyed by gastric contents
HOWEVER may also resist dissolution in the intestine -> low absorption |
|
why is the sublingual route effective for GTN? (4) why would we think it wouldn't be so?
|
GTN - non ionic & high lipid soluble
- is very potent - need relatively few molecules for therapeutic effect - venous drainage from mouth is to SVC, so limited 1st pass metabolism - first pass metabolism would destroy GTN if swallowed as tab the sublingual route has a low surface area which theoretically would decrease absorption |
|
what are two negatives and two positives for using the rectal route of drug administration?
|
-ve:
- often irregular & incomplete absorption - often irritates rectal mucosa +ve - ~50% absorption bypasses liver first pass - useful when pt vomiting/unconscious |
|
what kind of first pass metabolism are parenteral methods subject to?
|
lung
especially weak bases & those not ionized @ blood pH |
|
how are SC & IM drugs absorbed?
|
simple diffusion along gradient
|
|
what factors limit SC/IM absorption (2)
|
SA of absorbing capillary membrane
solubility of substance in interstitial fluid |
|
what are the positive features of IV route of admin (3)?
|
- circumvents absorption problems
- allows accuracy & immediacy not otherwise possible - suitable for large volumes |
|
what are the negative features of IV admin? (3)
|
can't go back
can't use for oily/insoluble drugs (WHY) need a patent vein |
|
what happens if we use an irritating drug via SC route?
|
severe pain, necrosis, slough
|
|
what features of SC route lead to sustained effect? how can this be prolonged?
|
constant & slow absorption
prolonged by adding vasoconstrictor or by using insoluble preparation |
|
what human factor greatly increases absorption via IM route?
|
blood flow to area
|
|
how does presence of subcutaneous fat influence rate of absorption?
|
decreases, since poorly perfused
|
|
what characteristic of the lungs facilitates rapid absorption of volatile /atomized drugs?
|
large surface area
|
|
when is systemic absorption the goal of topical nasal therapy? when is it an unwanted side effect?
|
ADH therapy (desired)
Local anaesthesia (not desired) |
|
which of the epidermis vs dermis acts as a barrier to topical absorption of drugs to skin? when is this clinically relevant
|
epidermis
dermis freely permeable to solutes relevant when skin barrier has been disrupted (abraded, burned, denuded skin) |
|
what is inunction?
|
suspending skin drugs in oily vehicle to increase absorption
|
|
how are eye drugs usually absorbed & when is this clinically important?
|
through the cornea
corneal infection/trauma results in rapid absorption |
|
what is bioequivalence?
|
same active ingredients
identical in strength/concentration, dosage form & route of admin same rate & extent of bioavailability of active ingredient |
|
where would a drug with Vd = 3L be distributed? how about Vd = 16L? Vd >46L?
|
3L - plasma only (plasma vol 3L)
16L - extracellular H20 (3L plasma plus 10-13L interstitial fluid) >46 likely sequestered in depot as body only contains 40-46L fluid |
|
what kinds of organs receive most of a drug during the first few minutes after absorption?
|
heart, liver, kidney, brain & other well perfused organs
|
|
how long does delivery of a drug to muscle, most viscera & fat take after absorption?
|
several minutes to hours before steady state
|
|
what factors, as well as blood flow, determine rate of distribution? (4)
|
- highly permeable capillary endothelium means distro is rapid into interstitium, except in brain
- lipid insoluble drugs can't permeate membranes easily -> limited distro - drug binding to plasma proteins eg albumin acid drugs limits access to cellular sites of action - accumulation in tissues in higher conc than expected due to pH gradients, binding to intracellular contituents or partitioning into lipid |
|
what lesson does thiopental teach us about distribution?
|
successive doses of thiopental accumulate in fat & can become thiopental reservoirs.
Thiopental, on first dose, has a rapid onset of anaesthetic but also of termination, since it doesn't actually bind to anything in the brain. Thiopental diffuses into other tissues eg muscle, so plasma conc falls. Fat reservoirs can maintain plasma concentration and therefore brain concentration at/above anaesthetic threshhold -> can become long acting |
|
how does the CNS pose problems to drug distribution?
|
tight junctions predominate & aqueous bulk flow is therefore severely restricted -> less drugs can get in
highly lipid soluble drugs can get into CNS but strongly ionized agents are usually unable to enter CNS from circulation |
|
what plasma proteins bind acidic drugs? basic drugs?
|
albumin - acidic
a1-acid glycoprotein - basic |
|
what normal drug processing activities are prevented by plasma protein binding? (2)
|
- limits concentration of drug at tissues & locus of action (only unbound drug is in equilibrium across membranes)
- glomerular filtration (conc of free drug in plasma not immediately changed) |
|
what renal drug processing function is not limited by binding to plasma protein & why?
|
renal tubular secretion/biotransformation since these processes lower free drug concentration, leading to dissociation of drug - protein complex
|
|
what kinds of molecules do drugs normally bind to in tissues & is tissue binding of drugs generally reversible/irreversible?
|
proteins/phospholipids/nucleoproteins
generally reversible |
|
why is fat a stable drug reservoir?
|
relatively low blood flow
|
|
how does bone act as a drug reservoir?
|
tetracycline antibiotics & heavy metals can adsorb onto the bone crystal surface & be incorporated into the lattice, thus bone can become a reservoir for slow release of toxic agents for a long time after exposure has ceased
|
|
what is the major transcellular reservoir?
|
GI tract
|
|
what is redistribution of a drug?
|
when drug effect terminates because the drug has been redistributed from its site of action to other tissues/sites
esp when a highly lipid soluble drug acting on CNS/CVS administered rapidly IV/inhaled |
|
how do drugs cross the placenta?
|
simple diffusion esp lipid soluble, non ionized drugs
|
|
when is the volume of distribution much larger than the animal itself?
|
when a drug binds preferentially to tissues at the expense of plasma
|
|
what size volume of distribution would an ionized molecule trapped in plasma have?
|
small
|
|
what is the usefullness of volume of distribution?
|
hypothetical measure of how well a drug is removed from the plasma and distributed to the tissues
|
|
how would the volume of distribution distinguish between drugs that are not highly bound to plasma but don't enter the cell vs those which enter the cell freely?
|
Vd in non cell entering would be volume of extracellular fluid (0.2L/kg) whereas those entering cells freely would be total body water volume (0.55L/kg)
|
|
how does the one compartment model limit our evaluation of the volume of distribution?
|
drugs will not be distributed to all the tissues evenly, this only looks at whether drug is in plasma or not
|
|
how does volume of distribution relate dose and concentration
|
a low volume of distribution means the concentration > dose ie H20 soluble, highly bound to plasma protein
a high vol of distribution means dose>concentration ie lipid soluble, highlhy bound to tissues |
|
give example of 3 drugs with low volume distribution
|
warfarin
amoxycillin gentamicin |
|
give example of 4 drugs with high volume of distribution
|
diazepam
digoxin amitryptiline chloroquin |
|
what is the formula for calculating volume of distribution?
|
Vd = dose (amount of drug in body)
____________ concentration in plasma |
|
how does volume of distribution affect our calculation of drug loading doses?
|
if you know the desired drug concentration in plasma & the volume of distro (in L/kg) & the pts weight, you can change the equation around to:
dose = Vd x target concentration |
|
how does Vd affect our calculation of top up doses if the drug is present but the concentration too low?
|
loading dose = (target conc - measured conc) x Vd
|
|
why is drug biotransformation necessary? (2)
|
because most active drugs are non polar and polar drugs are more easily excreted
also because duration of action would be very long if left polar vs changed into (usually less active) metabolite |
|
what are the two main categories of drug biotransformation and what distinguishes them?
|
phase I = NONSYNTHETIC - drugs are oxidised/reduced to a more polar form
phase II = SYNTHETIC polar group is conjugated to a drug drugs undergoing phase II conjugation may have already undergone phase I transformation (& vice versa) |
|
where does drug biotransformation mainly occur? where else may it occur (5)
|
liver
also GI, lungs, skin, kidneys, brain |
|
give 4 examples of drugs which are more extensively metabolised in the intestine than the liver
|
clonazepam
chlorproazine cyclospine midazolam (50% intestinal metabolism) |
|
what in the lower gut is capable of many biotransformation reactions?
|
microbes
|
|
give an example of a drug that can be metabolised by gastric acid
|
penicillin
|
|
give an example of a drug that can be metabolised by digestive enzymes
|
polypeptides eg insulin
|
|
give an example of a drug that can be metabolised by enzymes in intestinal wall
|
sympathomimetic catechoamines
|
|
where are biotransformations catalysed at the subcellular level (4)
|
ER, mitochondria, cytsol, lysossomes
occasionally nuc envelope/plasma membrane |
|
what are microsomes and which kind are full of oxidative drug metabolism enzymes?
|
microsomes are vesicles formed from leftover endoplasmic reticulum
the ones formed from smooth ER contain the enzymes |
|
?? how much detail do we need on the P450 system ??
|
...
|
|
what are the two microsomal enzymes that are key in microsomal biotransformation? which is more important? why?
|
NADPH-cytochrome P450 reductase
cytochrome P450 which is more important - it is more abundant in the liver, so P450 heme reduction is a rate limiting step in hepatic drug oxidation |
|
why is P450 so named?
|
in its reduced (ferrous) form it binds CO to give a complex that maximally absorbs light at 450nm
|
|
what is required for microsomal drug oxidation? (4)
|
p450
p450 reductase NADPH molecular oxygen |
|
what is the common structural feature of drugs metabolised in the p450 system?
|
high lipid solubility
|
|
how do P450s compare with many other enzymes in terms of speed?
|
sluggish & reactions are slow
|
|
?? HOW MUCH DETAIL DO WE NEED TO KNOW FOR PHASE I reactions??
|
???
|
|
what is the significance of CYP3A4?
|
is the P450 isoform responsible for metabolising >50% prescription drugs metabolised by the liver
|
|
?? how much detail about enzyme inducers & inhibitors?
|
...
|
|
what is required for increased P450 synthesis?
|
increased transcription/translation (mediated by cell receptors for the inducer) & increased synthesis of heme (prosthetic cofactor)
|
|
what is a cruciferous vegetable?
|
spinach/kale/tatsoi etc
induce CYP1A p450 genes |
|
what is the common mechanism of inhibiting p450 enzymes?
|
binding or interact with the P450 heme iron -> inactivate enzyme/competitively inhibit binding etc
|
|
what distinguishes phase II reactions?
|
they are synthetic
vs nonsynthetic phase I reactions |
|
are phase I or phase II reactions generally faster?
|
phase II
|
|
what are the general characteristics of conjugates formed by phase II reactions?
|
polar, readily excreted, often inactive
|
|
what are the most dominant phase II enzymes?
|
UGTs
uridine 5'-diphosphate - glucuronosyl transferases |
|
?? need to know metabolism of paracetamol to hepatotoxic metabolites in detail?
|
katzung fig 4-5
|
|
what percentage of paracetamol metabolism is phase II vs phase I? why is this important
|
95% phase II
the remaining 5% phase I becomes important at very high doses as P450 pathway becomes increasingly important |
|
what hepatic compound is necessary for safe phase I metabolism of paracetamol?
|
GSH (glutathione)
is depleted faster than it can be regenerated with time, leading to accumulation of reactive toxic metabolite |
|
which enzymes do charcoal broiled foods & cruciferous vegetables induce?
|
CYP1A
|
|
what does grapefruit juice inhibit?
|
CYP3A metabolism of coadministered drug substrates
|
|
what affect does cigarette smoke have on enzyme induction?
|
increases in some drugs
|
|
which drugs are enzyme inducing? (5)
|
various sedative hypnotics
antipsychotics anticonvulsants rifampicin (anti TB) insecticides |
|
how do sedatives and certain antipsychotics affect warfarin levles?
|
routine use of these may lead to considerably higher doses of warfarin required & cessation of these may lead to reduced anticoagulant metabolism & bleeding
|
|
what is the inductive explanation for drug tolerance?
|
an inducer may enhance not only the metabolism of other drugs but its own metabolism
|
|
apart from liver, what other system disease can impair drug metabolism & how?
|
cardiac - by preventing blood flow to liver of very rapidly metabolised drugs
thyroid (esp hypo) bacterial/viral infections -> inflamm mediators/cytokines & NO release |
|
what is drug clearance?
|
the factor that predicts rate of elimination in relation to drug concentration
|
|
what is the formula for clearance?
|
C = rate of elimination/concentration
|
|
how is drug clearance additive?
|
drug elimination may involve processes occuring in kidney, lung, liver & other organs. total systemic clearance equals CL kidney + CLliver + CLother
|
|
what are the two main sites of drug elimination?
|
kidneys & liver
|
|
what represents renal clearance?
|
clearance of unchanged drug in urine
|
|
how are drugs cleared in liver? (3)
|
biotransformation to metabolites
excretion of unchanged drug into bile both |
|
how does rate of drug elimination compare to concentration?
|
directly proportional
clearance is constant over concentration range |
|
what is first order elimination? how can it be calculated?
|
when rate of elimination = clearance x concentration
estimated by calculating the area under the curve of time/concentration profile after a dose? |
|
how can clearance be related to area under the curve?
|
clearance = dose/AUC
|
|
how does first order elimination clearance relate to capacity-limited (or saturable/non linear/ Michaelis-Mentin elimination)?
|
first order elimination is not saturable & the rate of drug elimination is directly proportional to concentration
capacity limited elimination means that clearance will vary depending on the concentration of drug achieved & is saturable |
|
which are the three drugs for which clearance has no real meaning & why?
|
aspirin, ethanol, phenytoin
concentration will keep rising as long as dosing continues (if dosing rate exceeds elimination capacity, steady state cannot be achieved) |
|
what is the equation to relate rate of elimination in capacity limited elimination?
|
rate of elimination = Vmax x C
________ Km + C where V max is max elimination capacity Km is drug concentration where rate of elimination is 50% of Vmax |
|
how does flow dependent elimination relate to capacity limited elimination?
|
flow dependent - some drugs cleared so readily by organ that most of drug is eliminated on first pass ie blood flow determines rate of elimination
capacity limited drug elimination has no relevance to blood flow & can be saturated by drug concentration |
|
what is the formula for half life in a single compartment?
|
t1/2 = log2 x Vd / CL
nb log2 approx equal to 0.7 |
|
when does the "true" half life exceed that from the half life formula?
|
in multicompartment models (most drugs)
|
|
what is the accumulation factor? what does the accumulation factor equal for a drug given every half life?
|
an index of accumulation
accumulation is inversely proportional to the fraction of the dose lost in each dosing interval ie AF = 1/1- fraction remaining so for dose every half life AF = 1/0.5 = 2 |
|
what are the 3 primary processes of pharmacokinetics?
|
absorption
distribution elimination |
|
what is volume of distribution?
|
the measure of apparent space in the body available to contain the drug
|
|
what links pharmacokinetics & pharmacodynamics?
|
concentration
|
|
what is steady state?
|
pseudo zero order elimination
elimination rate almost independent of concentration average total amount of drug in the body does not change over multiple dosing cycles |
|
what is first pass effect?
|
elimination of drug occuring after administration but before it enters systemic circulation
|
|
how do we calculate loading dose?
|
target conc (mg/L) x vol distribution (L/kg)
|
|
how do we calculate IV maintenance dose?
|
Infusion rate
= target steady state conc x clearance rate divided by salt & molar correction factor |
|
how do we calculate oral maintenance dose?
|
avg target steady state x clearance x dosage interval
divided by bioavailability x salt corr x molar corr |
|
when do ionizable forms of drugs cross membranes best?
|
when they are in their non ionized form
|
|
when would a weak acid be in its best form to cross the lipid membrane? a weak base?
|
weak acid - non ionized at more acid pH
weak base - non ionized at more alkaline pH |
|
how can we use pH to trap drugs in the urine for excretion?
|
by adjusting urine pH to make sure drug is in ionized state & hence can't be reabsorbed from the tubule
|
|
give a clinical example of how we could possibly use urine to excrete a drug?
|
methamphetamine, a weak base, is freely filtered at the glomerulus but can be rapidly reabsorbed at the renal tubule
ammonium chloride acidifies the urine which converts a larger fraction to charged form, poorly absorbed & thus rapidly eliminated however there is a risk of renal damage with forced diuresis & urinary pH manipulation |